CD4 and glioblastoma: In glioblastoma, a typical immunologically ‘cold’ tumor, the suppressive Treg cells were converted toward CD4 effector T cells by an agonistic antibody (αGITR), which promoted the cure rates in GBM models combined with PD1 antibodies (240).